Lijun Xin

Title: Lijun Xin: Innovator in Immunomodulation and Pharmaceutical Development

Introduction

Lijun Xin is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of immunomodulation. With a total of 2 patents, his work focuses on developing innovative compounds that can aid in treating various diseases.

Latest Patents

Lijun Xin's latest patents include a biphenyl compound that serves as an immunomodulator, along with its preparation method and applications. This pharmaceutical composition comprises the compound as an active ingredient, showcasing its potential in medical applications. Another notable patent is a quinoline derivative that exhibits indoleamine-2,3-dioxygenase inhibitory activity. This compound, represented by a specific general Formula (I), is designed for use in the manufacture of a medicament aimed at immunomodulating and treating diseases associated with IDO expression abnormalities and tryptophan metabolism issues.

Career Highlights

Lijun Xin is currently associated with Shenzhen Chipscreen Biosciences, Ltd., where he continues to push the boundaries of pharmaceutical research. His innovative approach and dedication to developing effective treatments have positioned him as a key figure in the industry.

Collaborations

Throughout his career, Lijun Xin has collaborated with talented individuals such as Lin Yang and Chao Fu. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical field.

Conclusion

Lijun Xin's contributions to immunomodulation and pharmaceutical development highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.